Skip to main content
SpringerLink
Log in

Anxiety disorders and schizophrenia

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Anxiety symptoms and disorders have long been described in schizophrenia. This article reviews the epidemiology, phenomenology, and neurobiologic underpinnings of comorbid anxiety symptoms and disorders in schizophrenia. Recent literature was obtained by Medline searches using key words relating to schizophrenia and anxiety symptoms or disorders. There is some evidence that anxiety may be a core symptom dimension in schizophrenia, although further work is required. There is evidence that comorbid obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and social anxiety disorder are all more common than expected by chance in schizophrenia, although additional work is needed to determine the mechanisms that underlie these associations and their clinical implications. In the interim, however, the data emphasize the importance of assessing and treating comorbid anxiety symptoms and disorders in schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Vaswani S: Schizophrenia with and without comorbid anxiety disorders. Paper presented at the 24th National Conference of the Anxiety Disorders Association of America 2004. Miami, FL; March 11–14, 2004.

  2. Wetherell JL, Palmer BW, Thorp SL, et al.: Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2003, 64:1476–1482. This study investigated the impact on quality of life that anxiety symptoms have in schizophrenia patients, and found that anxiety symptoms were significantly associated with poorer quality of life. In the majority, the proportion of variance in quality of life attributed to anxiety was greater than that caused by depressive symptoms.

    Article  PubMed  Google Scholar 

  3. Lysaker PH, Bell MD, Bioty SM, Zito WS: The frequency of associations between positive and negative symptoms and dysphoria in schizophrenia. Compr Psychiatry 1995, 36:113–117.

    Article  PubMed  CAS  Google Scholar 

  4. Emsley RA, Oosthuizen P, Joubert A, et al.: Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J Clin Psychiatry 1999, 60:747–751.

    Article  PubMed  CAS  Google Scholar 

  5. Malla AK, Norman RMG, Manchanda R, et al.: One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002, 54:231–242.

    Article  PubMed  Google Scholar 

  6. Emsley R, Rabinowitz J, Torreman M, The RIS-INT-35 Early Psychosis Global Working Group: The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recentonset psychosis. Schizophr Res 2003, 61:47–57.

    Article  PubMed  Google Scholar 

  7. Scarr E, Pavey G, Copolov D, Dean B: Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects. Schizophr Res 2004, in press.

  8. Yasuno F, Suhara T, Ichimiya T, et al.: Decreased 5-HT1a receptor binding in amygdala of schizophrenia. Biol Psychiatry 2004, 55:439–444.

    Article  PubMed  CAS  Google Scholar 

  9. Ritsner M, Maayan R, Gibel A, et al.: Elevation of the cortisol/ dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol 2003, in press.

  10. Strous RD, Maayan R, Lapidus R, et al.: Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 2003, 60:133–141.

    Article  PubMed  CAS  Google Scholar 

  11. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A: Obsessive-compulsive symptoms induced by atypical antipsychotics: a review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:333–346. A review of atypical antipsychotics and the induction of OC symptoms, with discussion of possible pathophysiologic mechanisms.

    Article  PubMed  Google Scholar 

  12. Eisen JL, Beer DA, Pato MT, et al.: Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder [see comments]. Am J Psychiatry 1997, 154:271–273.

    PubMed  CAS  Google Scholar 

  13. Poyurovsky M, Fuchs C, Weizman A: Obsessive-compulsive disorder in patients with first-episode schizophrenia. Am J Psychiatry 1999, 156:1998–2000.

    PubMed  CAS  Google Scholar 

  14. Nechmad A, Ratzoni G, Poyurovsky M, et al.: Obsessive-compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry 2003, 160:1002–1004. This study investigates the prevalence of OCD (26%) in adolescents with schizophrenia spectrum disorders.

    Article  PubMed  Google Scholar 

  15. Ohta M, Kokai M, Morita Y: Features of obsessive-compulsive disorder in patients primarily diagnosed with schizophrenia. Psychiatry Clin Neurosci 2003, 57:67–74.

    Article  PubMed  Google Scholar 

  16. Poyurovsky M, Kurs R, Weizman A: Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder. J Clin Psychiatry 2003, 64:5.

    Article  Google Scholar 

  17. Sobin C, Blundell ML, Willer F, et al.: Evidence of schizotypy subtype in OCD. J Psychiatr Res 2000, 34:15–24.

    Article  PubMed  CAS  Google Scholar 

  18. Matsunaga H, Kiriike N, Matsui T, et al.: Obsessive-compulsive disorder with poor insight. Comp Psychiatry 2002, 43:150–157.

    Article  CAS  Google Scholar 

  19. Remington G, Kapur S: D2 and 5HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET. J Clin Psychiatry 1999, 60(suppl):15–19.

    PubMed  CAS  Google Scholar 

  20. Carlsson ML: On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive-compulsive disorder and attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:5–26.

    Article  PubMed  CAS  Google Scholar 

  21. Abbruzzese M, Ferri S, Scarone S: The selective breakdown of functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia 1997, 35:907–912.

    Article  PubMed  CAS  Google Scholar 

  22. Cavallaro R, Cavedini P, Mistretta P, et al.: Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled double dissociation study. Biol Psychiatry 2003, 54:437–443. Double-dissociation study confirming the involvement of different frontal lobe systems in the pathogenesis of schizophrenia and OCD.

    Article  PubMed  Google Scholar 

  23. Kwon JS, Shin YW, Kim CW, et al.: Similarity and disparity of obsessive-compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J Neurol Neurosurg Psychiatry 2003, 74:962–964.

    Article  PubMed  CAS  Google Scholar 

  24. Reznik I, Yavin I, Stryjer R, et al.: Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study. Pharmacopsychiatry 2004, 37:52–56.

    Article  PubMed  CAS  Google Scholar 

  25. Poyurovsky M, Bergman Y, Shoshani D, et al.: Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol 1998, 21:97–100.

    PubMed  CAS  Google Scholar 

  26. Berman I, Sapers BL, Chang HH, et al.: Treatment of obsessivecompulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol 1995, 15:206–210.

    Article  PubMed  CAS  Google Scholar 

  27. Strakowski SM, Tohen M, Stroll AL, et al.: Comorbidity in psychosis at first hospitalization. Am J Psychiatry 1993, 150:752–757.

    PubMed  CAS  Google Scholar 

  28. Goodwin RD, Amador XF, Malaspina D, et al.: Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr Res 2003, 61:89–95. This article investigates the relationship between anxiety and substance use disorders in schizophrenia. Those with panic attacks (45%) had significantly increased rates of comorbid psychiatric disorders, psychotic symptoms, suicidality, an increased risk of lifetime comorbid alcohol or other substance use disorders, and mental health care use compared with those without.

    Article  PubMed  Google Scholar 

  29. Cutler JL, Siris SG: #x201C;Panic-like#x201D; symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications. Compr Psychiatry 1991, 32:465–473.

    Article  PubMed  CAS  Google Scholar 

  30. Siris SG, Mason SE, Shuwall MA: Histories of substance abuse, panic and suicidal ideation in schizophrenic patients with histories of post-psychotic depressions. Prog Neuropsychopharmacol Biol Psychiatry 1993, 17:609–617.

    Article  PubMed  CAS  Google Scholar 

  31. Bayle FJ, Krebs MO, Epelbaum C, et al.: Clinical features of panic attacks in schizophrenia. Eur Psychiatry 2001, 16:349–353.

    Article  PubMed  CAS  Google Scholar 

  32. Galynker I, Ieronimo C, Perez-Acquino A, et al.: Panic attacks with psychotic features. J Clin Psychiatry 1996, 57:402–406.

    PubMed  CAS  Google Scholar 

  33. Mandalos GE, Szarek BL: New-onset panic attacks in a patient treated with olanzapine. J Clin Psychopharmacol 1999, 19:191.

    Article  PubMed  CAS  Google Scholar 

  34. Higuchi H, Kamata M, Yoshimoto M, et al.: Panic attacks in patients with chronic schizophrenia: a complication of longterm neuroleptic treatment. Psychiatry Clin Neurosci 1999, 53:91–94.

    Article  PubMed  CAS  Google Scholar 

  35. Arlow PB, Moran ME, Bermanzohn PC, Siris SG: Cognitive behavioral treatment of panic attacks in chronic schizophrenia. J Psychother Pract Res 1997, 6:145–150.

    PubMed  CAS  Google Scholar 

  36. Seedat S, Stein MB, Oosthuizen PP, et al.: Linking posttraumatic stress disorder and psychosis: a look at epidemiology, phenomenology, and treatment. J Nerv Ment Dis 2003, 191:675–681.

    Article  PubMed  Google Scholar 

  37. Hamner MB, Fruch BC, Elmer HG, et al.: Psychotic features in post traumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis 2000, 188:217–221.

    Article  PubMed  CAS  Google Scholar 

  38. Cerbone A, Sautter J, Manguno-Mire G, et al.: Differences in smooth pursuit eye movement between posttraumatic stress disorder with secondary psychotic symptoms and schizophrenia. Schizophr Res 2003, 63:59–62.

    Article  PubMed  Google Scholar 

  39. Turnbull G, Bebbington P: Anxiety and the schizophrenic process: clinical and epidemiological evidence. Soc Psychiatry Psychiatr Epidemiol 2001, 36:235–243.

    Article  PubMed  CAS  Google Scholar 

  40. Shaw K, McFarlane AC, Bookless C, Air T: The etiology of postpsychotic posttraumatic stress disorder following a psychotic episode. J Trauma Stress 2002, 15:39–46.

    Article  PubMed  Google Scholar 

  41. Kennedy BL, Dhaliwal N, Pedley L, et al.: Post-traumatic stress disorder in subjects with schizophrenia and bipolar disorder. J Ky Med Assoc 2002, 100:395–399.

    PubMed  Google Scholar 

  42. Meyer H, Taiminen T, Vuori T, et al.: Post-traumatic stress disorder symptoms related to psychosis and acute involuntary hospitalization in schizophrenic and delusional patients. J Nerv Ment Dis 1999, 187:343–352.

    Article  PubMed  CAS  Google Scholar 

  43. Resnick SG, Bond GR, Mueser KT: Trauma and posttraumatic stress disorder in people with schizophrenia. J Abnorm Psychol 2003, 112:415–423. This article investigates the relationship between symptom severity, a lifetime history of trauma, and PTSD in patients with schizophrenia, finding trauma across lifetime was associated with greater PTSD severity. PTSD symptoms correlated with greater emotional distress, but were not associated with schizophrenia-specific symptoms.

    Article  PubMed  Google Scholar 

  44. Neria Y, Bromet EJ, Sievers S, et al.: Trauma exposure and posttraumatic stress disorder in psychosis: findings from a firstadmission cohort. J Consult Clin Psychol 2002, 70:246–251.

    Article  PubMed  Google Scholar 

  45. Gearon JS, Kaltman SI, Brown C, Bellack AS: Traumatic life events and PTSD among women with substance use disorders and schizophrenia. Psychiatr Serv 2003, 54:523–528. This article reports high rates of trauma, revictimization, and PTSD in women with schizophrenia and comorbid substance use disorders.

    Article  PubMed  Google Scholar 

  46. De Bellis MD: Developmental traumatology: a contributory mechanism for alcohol and substance use disorders. Psychoneuroendocrinology 2002, 27:155–170.

    Article  PubMed  Google Scholar 

  47. Jacobsen LK, Southwick SM, Korsten TR: Substance use disorders in patients with posttraumatic stress disorders: a review of the literature. Am J Psychiatry 2001, 158:1184–1190.

    Article  PubMed  CAS  Google Scholar 

  48. Gearon JS, Bellack AS, Tenhula WN: Preliminary reliability and validity of the Clinician-Administered PTSD Scale for schizophrenia. J Consult Clin Psychol 2004, 72:121–125. This paper provides evidence on the reliability and validity of a commonly used PTSD scale adapted for use in schizophrenia.

    Article  PubMed  Google Scholar 

  49. Hamner MB, Faldowski RA, Elmer HG, et al.: Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol 2003, 18:1–8.

    Article  PubMed  CAS  Google Scholar 

  50. Rosenberg SD, Mueser KT, Friedman MJ, et al.: Developing effective treatments for posttraumatic stress disorder among people with severe mental illness. Psychiatr Serv 2001, 52:1453–1461.

    Article  PubMed  CAS  Google Scholar 

  51. Strakowski SM, Tohen M, Stoll AL, et al.: Comorbidity in psychosis at first hospitalization. Am J Psychiatry 1993, 150:752–757.

    PubMed  CAS  Google Scholar 

  52. Cassano GB, Pini S, Saettoni M, et al.: Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry 1998, 59:60–68.

    PubMed  CAS  Google Scholar 

  53. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC: Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: the National Comorbidity Survey. Arch Gen Psychiatry 1996, 53:1022–1031.

    PubMed  CAS  Google Scholar 

  54. Pallanti S, Quercioli L, Hollander E: Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry 2004, 161:53–58. This study emphasizes the negative impact of SAD in schizophrenia, and suggests the usefulness of the Liebowitz Social Anxiety Scale in the assessment of such patients.

    Article  PubMed  Google Scholar 

  55. Stern RG, Frank D, Mera H: High social phobia scale scores in schizophrenia do not correlate with psychosis symptom severity scores. New Research Program and Abstracts of the 152nd Annual Meeting of the American Psychiatric Association. Washington, DC: May 18, 1999. Abstract NR239:131.

  56. Goldberg JO, Schmidt LA: Shyness, sociability, and social dysfunction in schizophrenia. Schizophr Res 2001, 48:343–349.

    Article  PubMed  CAS  Google Scholar 

  57. Tien AY, Eaton WW: Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry 1992, 49:37–46.

    PubMed  CAS  Google Scholar 

  58. Mikkelson EJ, Detlor J, Cohen DJ: School avoidance and social phobia triggered by haloperidol in patients with Tourette’s disorder. Am J Psychiatry 1981, 138:1572–1576.

    Google Scholar 

  59. Pallanti Quercioli L, Rossi A, Pazzagli A: The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation. J Clin Psychiatry 1999, 60:819–823.

    Article  Google Scholar 

  60. Halperin S, Nathan P, Drummond P, Castle D: A cognitivebehavioral group-based intervention for social anxiety in schizophrenia. Aust N Z J Psychiatry 2000, 34:809–813.

    Article  PubMed  CAS  Google Scholar 

  61. Kingsep P, Nathan P, Castle D: Cognitive behavioral group treatment for social anxiety disorder in schizophrenia. Schizophr Res 2003, 63:121–129.

    Article  PubMed  Google Scholar 

  62. McDougle CJ, Epperson CN, Pelton GH, et al.: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000, 57:794–801.

    Article  PubMed  CAS  Google Scholar 

  63. Sannomiya M, Katsu H, Nakayama K: A clinical study of emergent anxiety in neuroleptics-naïve, first-episode schizophrenia patients following treatment with risperidone [abstract]. Seishin Shinkeigaku Zasshi 2003, 105:643–658.

    PubMed  Google Scholar 

  64. Fleischhacker WW, Eerdekens M, Karcher K, et al.: Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second generation antipsychotic. J Clin Psychiatry 2003, 64:1250–1257.

    Article  PubMed  CAS  Google Scholar 

  65. McGavin JK, Goa KL: Aripiprazole. CNS Drugs 2002, 16:779–786.

    Article  PubMed  CAS  Google Scholar 

  66. Marder SR, Davis JM, Chouinard G: The affects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 1997, 58:538–546.

    PubMed  CAS  Google Scholar 

  67. Lee M, Meltzer H: Quetiapine is significantly superior to haloperidol and placebo in improving mood in patients with schizophrenia. Paper presented at the 7th World Congress of Biological Psychiatry. Berlin, Germany; July 1–6, 2001.

  68. Cutler AJ: Quetiapine effective in reducing anxiety: clinical evidence. Paper presented at the American Psychiatric Association Annual Meeting. New Orleans, LA; May 5–10, 2001.

  69. Littrell KH, Petty RG, Hilligos NM, et al.: The effect of olanzapine on anxiety among patients with schizophrenia: preliminary findings. J Clin Psychopharmacology 2003, 23:523–525.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Research Council Unit on Anxiety Disorders, Department of Psychiatry, University of Stellenbosch, PO Box 19063, 7505, Cape Town, Tygerberg, South Africa

    Jacqueline E. Muller MBChB, MMed

Authors
  1. Jacqueline E. Muller MBChB, MMed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liezl Koen MBChB, MMed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Soraya Seedat MBChB, FCPsych, MMed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robin A. Emsley MBChB, MMed, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel J. Stein MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muller, J.E., Koen, L., Seedat, S. et al. Anxiety disorders and schizophrenia. Curr Psychiatry Rep 6, 255–261 (2004). https://doi.org/10.1007/s11920-004-0074-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-004-0074-0

Keywords

Search

Navigation